DADC
RDUS

D.A. Davidson & Co’s Radius Health, Inc. RDUS Stock Holding History

D.A. Davidson & Co’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$9K – 2119
2017
Q2 		$9K Buy
+200
New +$7.64K ﹤0.01% 2083

Other funds holding RDUS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

D.A. Davidson & Co's RDUS Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Radius Health, Inc. (RDUS) in Q3 2017, closing a stake of 200 shares — an estimated $9K sold.

D.A. Davidson & Co first reported a position in RDUS in Q2 2017 and held it in 1 quarter. The position peaked at $9K in Q2 2017. 142 funds tracked by Wall St. Rank hold RDUS as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Radius Health, Inc. position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 200 Radius Health, Inc. shares in Q3 2017, an estimated $9K.
  • D.A. Davidson & Co first reported a position in Radius Health, Inc. in Q2 2017 and held it in 1 quarter.
  • D.A. Davidson & Co's Radius Health, Inc. position peaked at $9K in Q2 2017.
  • 142 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.